| Financial Year |
March 31 2023 |
| Monetary Funds |
1,676,154,210.73 |
| Held-for-trading Financial Assets |
469,095,811.85 |
| Notes Receivable |
-- |
| Accounts Receivable |
336,466,028.95 |
| Advances to Suppliers |
105,359,305.09 |
| Other Receivables |
126,404,046.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,205,503.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
157,837,418.94 |
| Total Current Assets |
2,894,522,324.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,716,405,630.66 |
| Investment Properties |
-- |
| Fixed Assetes |
1,001,066,600.12 |
| Under-construction Projects |
805,568,829.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
786,367,972.76 |
| R&D expenses |
328,209.25 |
| Goodwill |
4,317,496,072.49 |
| Long-Term Deferred and Prepaid Expenses |
12,832,096.53 |
| Deferred Income Tax Assets |
125,907,675.27 |
| Other Non-Current Assets |
209,363,621.29 |
| Sub-Total of Non-Current Assets |
9,713,308,438.17 |
| Total Assets |
12,607,830,763.15 |
| Short-Term Loans |
200,174,166.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
408,212,947.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
256,685,134.24 |
| Taxes Payable |
154,342,448.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
101,714,679.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,576,353.51 |
| Other Current Liabilities |
4,223,887.21 |
| Sub-Total of Current Liabilities |
1,495,058,405.65 |
| Long-term Loans |
469,148,468.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,026,324.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
699,035,413.56 |
| Total Liabilities |
2,194,093,819.21 |
| Paid-In Capital(Or Share Stock) |
1,265,730,523.00 |
| Capital Surplus |
2,943,017,404.72 |
| Surplus Reserve |
208,414,706.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,139,041,036.76 |
| Minority Stockholder's Interest |
862,207,622.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,551,529,321.76 |
| Owner's Equity（Stockholder's Equity） |
10,413,736,943.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,607,830,763.15 |
